{{DISPLAYTITLE:Technetium (<sup>99m</sup>Tc) nofetumomab merpentan}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470478313
| image = Technetium-99m nofetumomab merpentan skeletal.svg
| drug_name = Technetium (<sup>99m</sup>Tc) nofetumomab merpentan
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = Fab
| source = o
| target =  
<!-- Clinical data -->
| tradename = Verluma
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life = 10.5 hours
| excretion = [[Kidney|renal]] (64%)
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 165942-79-0
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}
'''Technetium (<sup>99m</sup>Tc) nofetumomab merpentan''' (trade name '''Verluma''') is a [[mouse]] [[monoclonal antibody]] derivative used in the diagnosis of [[lung cancer]],<ref>{{cite journal|pmid=10634533|year=2000|last1=Straka|first1=MR|last2=Joyce|first2=JM|last3=Myers|first3=DT|title=Tc-99m nofetumomab merpentan complements an equivocal bone scan for detecting skeletal metastatic disease from lung cancer|volume=25|issue=1|pages=54–5|journal=Clinical nuclear medicine|doi=10.1097/00003072-200001000-00013}}</ref> [[gastrointestinal cancer|gastrointestinal]], [[breast cancer|breast]], [[ovarian cancer|ovary]], [[pancreas cancer|pancreas]], [[kidney cancer|kidney]], [[cervix cancer|cervix]], and [[bladder carcinoma]].<ref>{{cite journal|pmid=9298295|year=1997|last1=Breitz|first1=HB|last2=Tyler|first2=A|last3=Bjorn|first3=MJ|last4=Lesley|first4=T|last5=Weiden|first5=PL|title=Clinical experience with Tc-99m nofetumomab merpentan (Verluma) radioimmunoscintigraphy|volume=22|issue=9|pages=615–20|journal=Clinical nuclear medicine|doi=10.1097/00003072-199709000-00007}}</ref> The antibody part, [[nofetumomab]], is attached to the [[chelator]] [[merpentan]], which [[isotopic labeling|links]] it to the [[radioisotope]] [[technetium-99m]] (<sup>99m</sup>Tc).<ref>[http://apps.who.int/medicinedocs/pdf/s4894e/s4894e.pdf WHO Drug Information]</ref>

==Nofetumomab==
Nofetumomab is an antibody fragment that recognises the pancarcinoma glycoprotein antigen [[EpCAM]].<ref>[https://books.google.co.uk/books?id=fF8d3eZ6SZ8C&pg=PA533&lpg=PA533&dq=nofetumomab+-merpentan&source=bl&ots=-uBFQaAY2i&sig=FGgu4DUYNcvuzsJjUg-wlgMB69c&hl=en&sa=X&ved=0ahUKEwj2uurWiNjKAhXHbRQKHfofDVo4FBDoAQgyMAM#v=onepage&q=nofetumomab%20-merpentan&f=false Molecular Biology of B Cells. p533]</ref> and/or [[CD20]]/[[MS4A1]]<ref>[http://www.creativebiolabs.net/Anti-MS4A1-Therapeutic-Antibody-VERLUMA-13782.htm technetium (99mTc) nofetumomab merpentan (TAB-711) ]</ref>

It is the [[Fragment antigen-binding|Fab]] part of murine MAb [[NR-LU-10]].<ref name=MARTK/>

==Merpentan==
The chelator part : merpentan is a [[phenthioate]] ligand, 2,3,5,6-tetrafluorophenyl-4,5-bis-5-[1-ethoxyethyl]-thioacetoamidopentanoate.<ref name=MARTK>[http://www.pharmacologicalsciences.us/pharmaceutical-chemistry/monoclonal-antibody-radionuclide-test-kits.html Monoclonal Antibody Radionuclide Test Kits]</ref>

===Phenthioate===
Phenthioate is an insecticide (Cidial) = O,o-dimethyl-S-(carbethoxy-phenylmethyl)dithiophosphate<ref>[http://www.google.mv/patents/US3934010 Insecticidal composition and method utilizing phosphoric acid phenylsulphonamide esters US 3934010 A]</ref>

==References==
{{reflist}}

{{Monoclonals for tumors}}

{{DEFAULTSORT:Technetium (99mtc) Nofetumomab Merpentan}}
[[Category:Technetium compounds]]
[[Category:Technetium-99m]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}